145 related articles for article (PubMed ID: 1663530)
1. Four year treatment with a long acting somatostatin analogue in a patient with Verner-Morrison syndrome.
Brunani A; Crespi C; De Martin M; Dubini A; Piolini M; Cavagnini F
J Endocrinol Invest; 1991 Sep; 14(8):685-9. PubMed ID: 1663530
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis of Verner-Morrison syndrome (VDHA) and its treatment with sandostatin an streptozocitin].
Várkonyi TT; Velösy B; Nagy I; Németh J; Lonovics J
Orv Hetil; 1993 Nov; 134(47):2599-602. PubMed ID: 8247522
[TBL] [Abstract][Full Text] [Related]
3. [Vipoma in an adolescent: treatment with a delayed-action somatostatin analog, octreotide or SMS 201-995, and surgical removal].
Brichard B; Fiasse R; Buts JP; Clapuyt P; Maes M; Rahier J; Cornu G
Acta Gastroenterol Belg; 1990; 53(2):188-97. PubMed ID: 2176428
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of a VIPoma by continuous subcutaneous infusion of somatostatin analogue (SMS 201-995).
Niitsu Y; Goto Y; Maeda M; Tsushima N; Watanabe N; Kohgo Y; Urushizaki I
Aliment Pharmacol Ther; 1988 Jun; 2(3):269-79. PubMed ID: 2856504
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
[TBL] [Abstract][Full Text] [Related]
6. [The somatostatin analog SMS 201-995 in long-term treatment of vipoma].
Christensen C
Ugeskr Laeger; 1990 Dec; 152(51):3851-3. PubMed ID: 2177234
[TBL] [Abstract][Full Text] [Related]
7. A case of the watery diarrhea-hypokalemia-achlorhydria syndrome: successful preoperative treatment of watery diarrhea with a somatostatin analogue.
Yoshioka M; Sakazume M; Fukagawa M; Seki T; Honma K; Uchida K; Yoshida K; Miyake Y; Yamaguchi K
Jpn J Clin Oncol; 1989 Sep; 19(3):294-8. PubMed ID: 2554028
[TBL] [Abstract][Full Text] [Related]
8. Development of resistance to a long-acting somatostatin analogue during treatment of two patients with metastatic endocrine pancreatic tumours.
Lamberts SW; Pieters GF; Metselaar HJ; Ong GL; Tan HS; Reubi JC
Acta Endocrinol (Copenh); 1988 Dec; 119(4):561-6. PubMed ID: 2849276
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
Williams G; Anderson JV; Williams SJ; Bloom SR
Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335
[TBL] [Abstract][Full Text] [Related]
10. Large cell carcinoma with calcitonin and vasoactive intestinal polypeptide-associated Verner-Morrison syndrome.
Pratz KW; Ma C; Aubry MC; Vrtiska TJ; Erlichman C
Mayo Clin Proc; 2005 Jan; 80(1):116-20. PubMed ID: 15667039
[TBL] [Abstract][Full Text] [Related]
11. [Metastasizing pancreatic vipoma. Its diagnosis and therapy with the somatostatin analog octreotide].
Scheffold N; Arnold R; Cyran J
Dtsch Med Wochenschr; 1995 Oct; 120(43):1463-7. PubMed ID: 7588006
[TBL] [Abstract][Full Text] [Related]
12. The somatostatin analogue SMS 201-995 in long-term treatment of vipoma. Case report.
Christensen C
Acta Chir Scand; 1989 Oct; 155(10):541-3. PubMed ID: 2557717
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin, as SMS 201-995, ameliorates the VIPoma syndrome.
Antonelli A; Gambuzza C; Bertoni F; Baschieri L
J Endocrinol Invest; 1993 Jan; 16(1):57-9. PubMed ID: 8383153
[TBL] [Abstract][Full Text] [Related]
14. Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma.
Koelz A; Kraenzlin M; Gyr K; Meier V; Bloom SR; Heitz P; Stalder H
Gastroenterology; 1987 Feb; 92(2):527-31. PubMed ID: 2878857
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes.
Vinik AI; Tsai ST; Moattari AR; Cheung P; Eckhauser FE; Cho K
Am J Med; 1986 Dec; 81(6B):23-40. PubMed ID: 2879447
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogue SMS 201-995 long term therapy for vipoma.
Juby LD; Burke DA; Axon AT
Postgrad Med J; 1987 Apr; 63(738):287-9. PubMed ID: 2891127
[TBL] [Abstract][Full Text] [Related]
17. [Mixed endocrine tumor of the pancreas (vipoma, glucagonoma). Treatment by somatostatin followed by one of its long-acting analogs].
Kaloustian E; Guillauseau PJ; Chayvialle JA; Veyssier P; Lallement PY; Latrive JP; Zylberait D; Lubetzki J
Presse Med; 1987 Dec; 16(44):2217-20. PubMed ID: 2893369
[TBL] [Abstract][Full Text] [Related]
18. Resolution of recurrent Verner-Morrison syndrome by resection of metastatic vipoma.
Nagorney DM; Bloom SR; Polak JM; Blumgart LH
Surgery; 1983 Feb; 93(2):348-53. PubMed ID: 6297109
[TBL] [Abstract][Full Text] [Related]
19. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
[TBL] [Abstract][Full Text] [Related]
20. [Vasoactive polypeptide-producing pancreatic carcinoma].
Gréczi K; Küronya P; Krutsay M
Orv Hetil; 1995 Sep; 136(37):2009-11. PubMed ID: 7566933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]